Bennett CF - Search Results

1

Chemically modified oligonucleotides exhibit decreased immune stimulation in mice.

Henry S, Stecker K, Brooks D, Monteith D, Conklin B, Bennett CF. Henry S, et al. Among authors: bennett cf. J Pharmacol Exp Ther. 2000 Feb;292(2):468-79. J Pharmacol Exp Ther. 2000. PMID: 10640282

2

Cationic lipids enhance cellular uptake and activity of phosphorothioate antisense oligonucleotides.

Bennett CF, Chiang MY, Chan H, Shoemaker JE, Mirabelli CK. Bennett CF, et al. Mol Pharmacol. 1992 Jun;41(6):1023-33. Mol Pharmacol. 1992. PMID: 1352033

3

In vitro and in vivo pharmacologic activities of antisense oligonucleotides.

Mirabelli CK, Bennett CF, Anderson K, Crooke ST. Mirabelli CK, et al. Among authors: bennett cf. Anticancer Drug Des. 1991 Dec;6(6):647-61. Anticancer Drug Des. 1991. PMID: 1663361 Review.

4

Inhibition of protein kinase C-alpha expression in human A549 cells by antisense oligonucleotides inhibits induction of intercellular adhesion molecule 1 (ICAM-1) mRNA by phorbol esters.

Dean NM, McKay R, Condon TP, Bennett CF. Dean NM, et al. Among authors: bennett cf. J Biol Chem. 1994 Jun 10;269(23):16416-24. J Biol Chem. 1994. PMID: 7911467 Free article.

5

An ICAM-1 antisense oligonucleotide prevents and reverses dextran sulfate sodium-induced colitis in mice.

Bennett CF, Kornbrust D, Henry S, Stecker K, Howard R, Cooper S, Dutson S, Hall W, Jacoby HI. Bennett CF, et al. J Pharmacol Exp Ther. 1997 Feb;280(2):988-1000. J Pharmacol Exp Ther. 1997. PMID: 9023316

6

Immune stimulation--a class effect of phosphorothioate oligodeoxynucleotides in rodents.

Monteith DK, Henry SP, Howard RB, Flournoy S, Levin AA, Bennett CF, Crooke ST. Monteith DK, et al. Among authors: bennett cf. Anticancer Drug Des. 1997 Jul;12(5):421-32. Anticancer Drug Des. 1997. PMID: 9236857

7

Cellular distribution of phosphorothioate oligodeoxynucleotides in normal rodent tissues.

Butler M, Stecker K, Bennett CF. Butler M, et al. Among authors: bennett cf. Lab Invest. 1997 Oct;77(4):379-88. Lab Invest. 1997. PMID: 9354772

8

Characterization and modulation of immune stimulation by modified oligonucleotides.

Boggs RT, McGraw K, Condon T, Flournoy S, Villiet P, Bennett CF, Monia BP. Boggs RT, et al. Among authors: bennett cf. Antisense Nucleic Acid Drug Dev. 1997 Oct;7(5):461-71. doi: 10.1089/oli.1.1997.7.461. Antisense Nucleic Acid Drug Dev. 1997. PMID: 9361905

9

Antisense oligonucleotides: is the glass half full or half empty?

Bennett CF. Bennett CF. Biochem Pharmacol. 1998 Jan 1;55(1):9-19. doi: 10.1016/s0006-2952(97)00214-1. Biochem Pharmacol. 1998. PMID: 9413924 Review.

10

Structural requirements for cationic lipid mediated phosphorothioate oligonucleotides delivery to cells in culture.

Bennett CF, Mirejovsky D, Crooke RM, Tsai YJ, Felgner J, Sridhar CN, Wheeler CJ, Felgner PL. Bennett CF, et al. J Drug Target. 1998;5(3):149-62. doi: 10.3109/10611869808995870. J Drug Target. 1998. PMID: 9606005

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

285 results

Search Page

Filters